• Home
  • News
  • Get involved
  • About NICE
  • Find guidance
  • NICE Pathways
  • Quality standards
  • Into practice
  • QOF

  • Conditions and diseases

    • Blood and immune system
    • Cancer
    • Cardiovascular
    • Central nervous system
    • Digestive system
    • Ear and nose
    • Endocrine, nutritional and metabolic
    • Eye
    • Gynaecology, pregnancy and birth
    • Infectious diseases
    • Injuries, accidents and wounds
    • Mental health and behavioural conditions
    • Mouth and dental
    • Musculoskeletal
    • Respiratory
    • Skin
    • Urogenital

  • Public health

    • Accidents and injuries
    • Alcohol
    • Behaviour change
    • Cancer
    • Cardiovascular disease
    • Child health
    • Child social care
    • Chronic illness
    • Diabetes
    • Drugs
    • Environmental health
    • Infectious diseases
    • Maternal health
    • Mental health
    • Non-communicable diseases
    • Obesity and diet
    • Occupational health
    • Older people
    • Physical activity
    • Sexual health
    • Smoking and tobacco
    • Transport
    • Vaccine preventable diseases
    • Working with and involving communities

  • Treatments, Procedures and Devices

    • Bones and joint surgery
    • Cardiovascular surgery
    • Cardiovascular system drug treatments
    • Clinical devices
    • Diagnostic imaging
    • Diagnostic procedures
    • Digestive tract and other abdominal organs surgery
    • Drug treatments
    • Endocrine system and breast surgery
    • Eye surgery
    • Nervous system surgery
    • Radiotherapy
    • Screening
    • Surgical procedures
    • Therapeutic procedures
    • Tissue and organ donation
    • Urogenital surgery

  • Guidance by type

    • Clinical Guidelines
    • Technology appraisals
    • Public health guidance
    • Diagnostics guidance
    • Interventional procedures guidance
    • Medical technologies guidance
    • Cancer service guidance
    • Quality standards

  • Guidance by date

    • View the guidance by date published
About NICE guidance Close
NICE technology appraisal guidance
Issued: October 2009
TA182

Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention

Select chapters to save or share
Important information about this guidance
1 Guidance
2 The technology
3 The manufacturer's submission
4 Consideration of the evidence
5 Implementation
6 Recommendations for further research
7 Related NICE guidance
8 Review of guidance
Appendix A: Appraisal Committee members and NICE project team
Appendix B: Sources of evidence considered by the Committee
  • Download PDF PDF icon
  • Download word documentMicrosoft Word document icon
  • Help
View the summary and implementation tools
Next

This is an extract from the guidance and may be misleading if read alone. The complete guidance is available at guidance.nice.org.uk/ta182

Important information about this guidance

This guidance was developed using the NICE single technology appraisals process: www.nice.org.uk/aboutnice/howwework/devnicetech/developing_nice_technology_appraisals.jsp

Next

Copyright © NICE 2012. All rights reserved.